Virax Share Price
NASDAQ: VRAX | OthersVirax Stock Performance
Virax Share Price Today
As of 19 November 2026, Virax Biolabs Group Limited's share price is $0.42. The stock opened at $0.45, compared to its previous close of $0.44. During today's trading session, Virax Biolabs Group Limited's share price traded between $0.43 and $0.49, with an average price of $0.46. Over the past 52 weeks, the stock has recorded a high of $13.18 and a low of $0.10. In terms of performance, Virax Biolabs Group Limited's share price has risen by 129.62% over the last six months and is up 6.38% on a year-on-year basis.
Virax Share Price Chart
Virax Annual Profit & Loss
All figures in USD
Virax Balance Sheet
All figures in USD Million
Virax Cash Flow
All figures in USD Million
Corporate Actions
About Virax
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
Virax Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.17 | $0.43 | -66.64% |
Oct 2026 | $2.23 | $1.28 | -41.82% |
Sep 2026 | $2.76 | $2.20 | -24.66% |
Aug 2026 | $2.78 | $2.92 | -2.01% |
Jul 2026 | $2.64 | $2.98 | +1.19% |
Jun 2026 | $0.19 | $2.94 | +1,509.29% |
May 2026 | $0.13 | $0.18 | +41.86% |
Apr 2026 | $0.18 | $0.13 | -40.28% |
Mar 2026 | $0.22 | $0.22 | -1.37% |
Feb 2026 | $0.28 | $0.22 | -20.07% |
Jan 2026 | $0.39 | $0.27 | -29.02% |
Dec 2025 | $0.40 | $0.39 | -2.28% |